The behaviour of tracer gallium-67 towards serum proteins
SW Gunasekera, LJ King, PJ Lavender - Clinica chimica acta, 1972 - Elsevier
When carrier free gallium-67 is administered iv in citrate form for tumour scanning,
radioactivity remaining in serum after three hours, it cannot be removed by ultrafiltration …
radioactivity remaining in serum after three hours, it cannot be removed by ultrafiltration …
[PDF][PDF] Is the Radiochemical Purity of Tc-99m Radiopharmaceuticals Decreasing?
M Moore, BA Rhodes - Journal of Nuclear Medicine, 1982 - Soc Nuclear Med
It is our contention that Ga-67 probably entersmalignant and normal soft tissuesby two
entirely different routes. We proposed this in a previouspublication, together with an overall …
entirely different routes. We proposed this in a previouspublication, together with an overall …
Brief Communication: Gallium-67 Citrate Uptake by Cultured Tumor Cells, Stimulated by Serum Transferrin
RG Sephton, AW Harris - Journal of the National Cancer …, 1975 - academic.oup.com
The uptake of the tumor scanning agent 67Ga citrate by cultured mouse tumor cells was
greatly enhanced with small additions of certain sera to the culture medium. This stimulation …
greatly enhanced with small additions of certain sera to the culture medium. This stimulation …
The role of transferrin and other receptors in the mechanism of 67Ga localization
R Weiner - International journal of radiation applications and …, 1990 - Elsevier
Gallium-67 is a useful adjunct in the diagnosis of a variety of diseases. At present 67Ga is
the radiopharmaceutical of choice for radionuclide imaging of tumors and can be used to …
the radiopharmaceutical of choice for radionuclide imaging of tumors and can be used to …
Preparation, biodistribution, and small animal PET of 45Ti-transferrin
AL Vavere, MJ Welch - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
Investigation of 45Ti-transferrin was pursued to provide insight into the mechanism of action
of titanocene dichloride, a chemotherapeutic agent currently in clinical trials. Methods …
of titanocene dichloride, a chemotherapeutic agent currently in clinical trials. Methods …
Relationship of iron metabolism to tumor cell toxicity of stable gallium salts
JS Rasey, NJ Nelson, SM Larson - … journal of nuclear medicine and biology, 1981 - Elsevier
The antitumor properties of citrated gallium nitrate (NSC 15200) have been tested using the
EMT-6/UW mouse sarcoma growing in vitro or in vivo. This tumor system has been used in …
EMT-6/UW mouse sarcoma growing in vitro or in vivo. This tumor system has been used in …
[PDF][PDF] Alteration Of Gallium Distribution in the Rat Using Periodically Related Elements Enhanced early imaging
JW Triplett, DWA Bourne, EE Kim… - Acta Radiologica …, 1981 - Taylor & Francis
1978). Unfortunately, this agent involves imaging problems which are related to plasma
protein binding. Specifically, gallium has an affinity for blood and soft tissue proteins, and …
protein binding. Specifically, gallium has an affinity for blood and soft tissue proteins, and …
[PDF][PDF] Uptake of gallium-67 in transfected cells and tumors absent or enriched in the transferrin receptor
CA Luttropp, JA Jackson, BJ Jones… - Journal of Nuclear …, 1998 - Soc Nuclear Med
(1). Subsequently, 67Gahas been shown to localize in a variety of tumors (2, 3). In nuclear
medicine, the utility of 67Ga as a tumor-imaging agent is variable. Many types of tumors …
medicine, the utility of 67Ga as a tumor-imaging agent is variable. Many types of tumors …
[引用][C] Red cell and plasma protein labeling with 113mIn
MH Adatepe, P Penkoske, A Van Amberg… - … International Journal of …, 1971 - Elsevier
113mIn is a radionuclide obtained from a tin-indium generator system. It is a transition
element from which organ specific scanning agents useful for liver, spleen, bone marrow …
element from which organ specific scanning agents useful for liver, spleen, bone marrow …
Application of lectins to tumor imaging radiopharmaceuticals
S Kojima, M Jay - European journal of nuclear medicine, 1986 - Springer
We investigated the in vitro binding of 125 I-lectins to Ehrlich ascites tumor (EAT) cells and in
vivo uptake of 125 I-lectins in Ehrlich solid tumor (EST) bearing mice. In in vitro binding …
vivo uptake of 125 I-lectins in Ehrlich solid tumor (EST) bearing mice. In in vitro binding …